Results 301 to 310 of about 6,410,935 (343)
Some of the next articles are maybe not open access.

Fusion/entry inhibitors as therapies for HIV

Expert Opinion on Emerging Drugs, 2001
A combination of three or more antiretroviral drugs, commonly termed 'highly active antiretroviral therapy' (HAART), has become the standard-of-care treatment for HIV-related disease in the developed world. Since its initiation in the mid 1990s, HAART has led to substantial reductions in both mortality and morbidity.
S, Redshaw, M, Westby
openaire   +2 more sources

Neutralizing antibodies to block viral entry and for identification of entry inhibitors

Antiviral Research
Neutralizing antibodies (NAbs) are naturally produced by our immune system to combat viral infections. Clinically, neutralizing antibodies with potent efficacy and high specificity have been extensively used to prevent and treat a wide variety of viral infections, including Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Human ...
Ee Hong Tam   +4 more
openaire   +2 more sources

The Clinical Landscape of HDAC Inhibitors

Medical Epigenetics, 2021
Arasu Ganesan
exaly  

Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study.

Journal of Hepatology, 2016
P. Bogomolov   +13 more
semanticscholar   +1 more source

Therapeutics and DNA Methylation Inhibitors

Medical Epigenetics, 2021
Shyamala C Navada
exaly  

HIV Integrase Inhibitors and Entry Inhibitors

2021
Daniel Bradshaw, Ranjababu Kulasegaram
openaire   +1 more source

Lipid raft-like liposomes used for targeted delivery of a chimeric entry-inhibitor peptide with anti-HIV-1 activity.

Nanomedicine : nanotechnology, biology, and medicine, 2017
M. Gómara   +5 more
semanticscholar   +1 more source

Inhibitors of Influenza Viral Entry

2021
RONG LIJUN   +3 more
openaire   +4 more sources

Entry Inhibitors

2016
Leah A. Burke, Roy M. Gulick
openaire   +1 more source

Home - About - Disclaimer - Privacy